Latest stories on PROK
ProKidney Announces At-the-Market Equity Offering Agreement
TipRanks26 · bearishgeneral
PROKIDNEY CORP. (PROK) files 8-K
SEC 8-K52 · neutralgeneral
ProKidney files $650M mixed securities shelf
The Fly48 · neutralgeneral
ProKidney price target lowered to $8 from $10 at Citi
The Fly34 · bearishanalyst
ProKidney Corp. (PROK) Discusses Rilparencel Mechanism and Role in Advanced Chronic Kidney Disease Transcript
Seeking Alpha54 · neutralproduct/pr
ProKidney to Host Virtual KOL Event to Recap Mechanism of Action Data Presented at ASN Kidney Week and Provide a Corporate Update
Business Insider53 · neutralproduct/pr
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
StockTitan56 · neutralproduct/pr
ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026
StockTitan63 · neutralproduct/pr
ProKidney (PROK) Nears A Pivotal Kidney Therapy Verdict
Yahoo Top58 · neutralgeneral
ProKidney: Do-Or-Die Phase 3 Meets A Dwindling Balance Sheet (Rating Downgrade)
Seeking Alpha28 · bearishproduct/pr
ProKidney GAAP EPS of -$0.15 misses by $0.01, revenue of $0.15M in-line
Seeking Alpha34 · bearishearnings
Prokidney Reports Q2 Eps 15c Consensus 14c
The Fly56 · neutralearnings
PROKIDNEY CORP. (PROK) files 8-K
SEC 8-K50 · neutralgeneral
ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights
StockTitan55 · neutralearnings
Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel’s Accelerated Approval Path
Yahoo Top67 · bullishproduct/pr
ProKidney Appoints Kenneth Locke as Chief Technical Officer | PROK Stock News
StockTitan63 · neutralproduct/pr
ProKidney GAAP EPS of -$0.14 beats by $0.01, revenue of $0.23M beats by $0.03M
Seeking Alpha56 · neutralearnings